Polymerase Chain Reaction (PCR) Industry Analysis Report: Key Trends, Drivers, and Forecast Insights

 This study helps professionals make sense of complex market trends and competitive shifts affecting the polymerase chain reaction (pcr) industry today.

 

 How Large Will The Polymerase Chain Reaction (PCR) Market Be By 2025?
 The polymerase chain reaction (pcr) market size has grown rapidly in recent years. It will grow from $11.42 billion in 2024 to $12.57 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising number of research facilities, increasing number of patients for chronic and infectious diseases, increasing prevalence of genetic and chronic disorders, increasing population, and growing geriatric population.
 
 The polymerase chain reaction (pcr) market size is expected to see strong growth in the next few years. It will grow to $18.27 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the rising concerns over food safety, the increasing demand for safe and high-quality food products, the rising demand for molecular diagnostics, demand for personalized medicine, focus on digital polymerase chain reaction (dPCR). Major trends in the forecast period include real-time polymerase chain reaction, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp
 
 What Are Key Factors Driving The Demand In The Global Polymerase Chain Reaction (PCR) Market?
 The rising demand for personalized medicine is expected to fuel the growth of the polymerase chain reaction (PCR) market going forward. Personalized medicine, also known as precision medicine, refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to individual characteristics of each patient. The demand for personalized medicine is increasing due to advancements in data analytics, patient-specific treatment responses, and the ability to tailor therapies based on individual genetic profiles. Polymerase Chain Reaction (PCR) helps personalized medicine by enabling the amplification and analysis of specific genetic sequences, allowing clinicians to tailor treatment plans based on individual genetic profiles. For instance, according to Personalized Medicine Coalition, a US-based professional membership organization, in 2022, approving 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the rising demand for personalized medicine is driving the growth of the polymerase chain reaction market.
 
 Comparative Analysis Of Leading Polymerase Chain Reaction (PCR) Market Segments
 The polymerase chain reaction (pcr)market covered in this report is segmented — 
 
 1) By Type: Conventional Polymerase Chain Reaction; Other Types
 2) By Indication: Infectious Diseases; Oncology; Genetic Disorders; Other Indications
 3) By Application: Medical; Non-Medical
 4) By End User: Hospitals And Clinics; Pharmaceutical And Biotechnology Industries; Diagnostic Centers; Academic And Research Organization
 
 Subsegments:
 1) By Conventional Polymerase Chain Reaction: Endpoint Pcr; Gel Electrophoresis-Based Pcr; Reverse Transcription Pcr (Rt-Pcr); Quantitative Pcr (Qpcr) For Gene Expression; Nested Pcr 
 2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr); Digital Pcr (Dpcr); Multiplex Pcr; Reverse Transcription-Quantitative Pcr (Rt-Qpcr); Isothermal Amplification (Lamp); Next-Generation Pcr (Ngs-Based Pcr Techniques); High-Throughput Pcr
 
 What Are The Key Trends Shaping The Polymerase Chain Reaction (PCR) Industry?
 Major companies operating in the polymerase chain reaction market are developing real-time polymerase chain reaction test kits to improve accuracy, efficiency, and ease of use in genetic analysis. Real-time polymerase chain reaction (RT-PCR) is a laboratory-developed test kit used to amplify and quantify specific DNA sequences in real-time. For instance, in November 2022, Cepheid, a US-based molecular diagnostics company, launched Xpert Xpress Multiplex Vaginal Panel (MVP), an FDA-cleared multiplex PCR test that can detect DNA from organisms associated with three distinct vaginal infections — bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis from a single vaginal swab sample. It enhances the capabilities of traditional polymerase chain reaction methods by providing real-time monitoring, quantification, and increased sensitivity and specificity, making it an indispensable tool in molecular biology and clinical diagnostics. 
 
 Who Are The Prominent Players In The Polymerase Chain Reaction (PCR) Business?
 Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics 
 
 View the full polymerase chain reaction (pcr) market report here:
 https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report
 
 Which Region Is Expected To Lead The Polymerase Chain Reaction (PCR) Market By 2025?
 North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company